Clinical Trial Update: The Effect of Intravenous Lipids on Lung Function in Acute Respiratory Distress Syndrome (ARDS) [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating intravenous lipids for lung function in acute respiratory distress syndrome was terminated with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Respiratory Distress Syndrome

Drugs mentioned

• Intravenous lipid emulsion (intravenous lipid emulsion)

Snippet

Sponsor: Methodist Research Institute, Indianapolis | Conditions: Acute Respiratory Distress Syndrome | Phase 2 | Status: TERMINATED | Results posted: 2014-05-26